India's Pharmaceutical Exports

Country Profile

Thailand

Thailand is a major destination for Indian pharmaceutical exports — $270M in FY 2025–26, with 1.8× growth over the past decade. Medicines accounts for 68% of shipments, with vaccines contributing $7.69M. The compound annual growth rate since FY2015 stands at 5.7%.

🇹🇭 #23 Destination · $270M · 1.8× growth since FY2015
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$270M
Exports FY2025–26 DGCIS
1.8×
Growth FY2015→2026
0.9%
Share of India Total
#23
Rank Among 178 Markets
5.7%
CAGR FY2015→2026
Thailand is a major destination for Indian pharmaceutical exports — $270M in FY 2025–26, with 1.8× growth over the past decade. Medicines accounts for 68% of shipments, with vaccines contributing $7.69M. The compound annual growth rate since FY2015 stands at 5.7%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $184M (68.0%) Medicine Ingredients $65.6M (24.3%) Surgical & Hospital Supplies $8.04M (3.0%) Vaccines $7.69M (2.8%) Traditional & Herbal $5.03M (1.9%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Thailand in the RBI overseas direct investment dataset (2011–2026).